-
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary StentingT Palmerini, LB Reggiani, GW Stone et al -
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized studyCuisset T, Deharo P, Quilici J et al.
-
Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting - A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) StudyE. A. Secemsky; R.W. Yeh; D.J. Kereiakes et al
-
Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data AnalysisPiccolo R, Feres F, Valgimigli M et al.
-
Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort StudySundström J, Hedberg J, Thuresson M et al.
-
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial FibrillationCannon CP, Bhatt DL, Oldgren J et al.
-
Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMIGiustino G, Mehran R, Stone GW et al.
-
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registryChandrasekhar J, Baber U, Mehran R et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
